News for Windtree Therapeutics, Inc. (WINTW)

U.S. stock futures were trading lower on Wednesday, after advancing for three consecutive sessions. Futures of major benchmark indices were lower in premarket trading.

Shares of GameStop Corp. GME rose sharply in today's pre-market trading after reporting better-than-expected fourth-quarter earnings. GameStop reported fourth-...

WARRINGTON, Pa., March 24, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (”œWindtree” or the ”œCompany”) (NasdaqCM: WINT), a biotechnology compan

Shares of The AZEK Company Inc. AZEK rose sharply in today's pre-market trading after James Hardie Industries plc JHX announced plans to acquire the company for...

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Thursday. The Dow traded up 0.63% to 42,230.78 whil...

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up ...

Transaction is part of the Company's new corporate strategy to become a revenue generating biotech WARRINGTON, Pa., March 20, 2025 (GLOBE NEWSWIRE) -- Windt

**media[571885]**

WARRINGTON, Pa., March 04, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (”œWindtree” or the ”œCompany”) (NasdaqCM: WINT), a biotechnology compan

WARRINGTON, Pa., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (”œWindtree” or the ”œCompany”) (NasdaqCM: WINT), a biotechnology company

WARRINGTON, Pa., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT) (”œWindtree” or the ”œCompany”), a biotechnology company

On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a notable transaction by acquiring an additional 131,552 shares of Windtree Therapeuti

WARRINGTON, Pa., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (”œWindtree” or the ”œCompany”) (NasdaqCM: WINT), a biotechnology company

The Company's oncology aPKCi inhibitor is a novel, first in class drug candidate WARRINGTON, Pa., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, I

**media[513602]**

Windtree Therapeutics appoints new board member

WARRINGTON, Pa., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (”œWindtree” or the ”œCompany”) (NasdaqCM: WINT), a biotechnology company

Windtree Therapeutics adopts new acquisition strategy

WARRINGTON, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (”œWindtree” or the ”œCompany”) (NasdaqCM: WINT), a biotechnology company